Works matching IS 09188959 AND DT 2020 AND VI 67 AND IP 1


Results: 14
    1

    SGLT2 inhibitor ipragliflozin attenuates breast cancer cell proliferation.

    Published in:
    Endocrine Journal, 2020, v. 67, n. 1, p. 99, doi. 10.1507/endocrj.ej19-0428
    By:
    • Shiho Komatsu;
    • Takashi Nomiyama;
    • Tomohiro Numata;
    • Takako Kawanami;
    • Yuriko Hamaguchi;
    • Chikayo Iwaya;
    • Tsuyoshi Horikawa;
    • Yuki Fujimura-Tanaka;
    • Nobuya Hamanoue;
    • Ryoko Motonaga;
    • Makito Tanabe;
    • Ryuji Inoue;
    • Toshihiko Yanase;
    • Daiji Kawanami
    Publication type:
    Article
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14